EXHIBIT 32.1

CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

Pursuant to Section 905 of the Sarbanes-Oxley Act of 2002 (subsections (a) and
(b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Georges
Benarroch, President and Chief Executive Officer of Kyto Biopharma, Inc., a
Florida corporation (the "Company"), do hereby certify, to the best of my
knowledge, that:

(1) the Company's Quarterly Report on Form 10-QSB for the six months ended
September 30, 2006, as filed with the Securities Exchange Commission on the date
hereof (the "Report") fully complies, in all material respects, with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
as amended; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company for
the periods presented therein.

Date: November 15, 2006

                          By: /s/ Georges Benarroch
                              ---------------------
                              Georges Benarroch
                              Acting President &
                              Chief Executive Officer
                              And Acting Chief Financial Officer